This refers to the editorial titled “Endorsement for a fee” (November 9), which has advocated a strict regulatory regime to enforce medical ethics. The malaise that has been highlighted is only the tip of the iceberg. While the Indian Medical Association (IMA) has endorsed only a few products, medical practitioners every day endorse various branded drugs in their prescriptions instead of prescribing generic drugs. To begin with, ethics have to be imbibed by the medical fraternity and cannot be imposed. Trade associations, which should be pursuing their legitimate aims, behave more like a cartel. The IMA endorses brands and issues boycott calls.
Also, it is anachronistic to argue that since the medical profession is a noble occupation, advertisements and endorsements cannot be allowed. It is necessary for the government to realise that the medical profession is a service sector and like any other service provider, it should be allowed to advertise and endorse. This measure will not only help the health care sector to run in a competitive atmosphere but also facilitate the patients’ decision-making process. However, transparency and consumer education are imperative before permitting such a course. Transparent advertisements and endorsements would educate medical services consumers and help them make informed decisions. Merely advocating a “strict regulatory regime” is no panacea. Such a regime will only breed corruption. In this context, the MCI’s surveillance role will be critical.
K D Singh, Expert (Law),
Competition Commission of India, New Delhi
